Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
2.100
-0.070 (-3.23%)
At close: Apr 28, 2026, 4:00 PM EDT
2.110
+0.010 (0.48%)
After-hours: Apr 28, 2026, 6:06 PM EDT
Microbot Medical Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Microbot Medical stock have an average target of 7.50, with a low estimate of 5.00 and a high estimate of 12. The average target predicts an increase of 257.14% from the current stock price of 2.10.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Microbot Medical stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +471.43% | Apr 14, 2026 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +138.10% | Feb 10, 2026 |
| Roth Capital | Roth Capital | Strong Buy Initiates $5.5 | Strong Buy | Initiates | $5.5 | +161.90% | Dec 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +471.43% | Nov 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +471.43% | Oct 15, 2025 |
Financial Forecast
Revenue This Year
4.39M
Revenue Next Year
9.64M
from 4.39M
Increased by 119.77%
EPS This Year
-0.35
from -0.29
EPS Next Year
-0.34
from -0.35
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 7.1M | 10.7M | ||
| Avg | 4.4M | 9.6M | ||
| Low | 2.8M | 8.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | - | 144.2% | ||
| Avg | - | 119.8% | ||
| Low | - | 94.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | -0.34 | -0.34 | ||
| Avg | -0.35 | -0.34 | ||
| Low | -0.36 | -0.33 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.